GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Bisolvon® | NA-274 | NA274
bromhexine is an approved drug
Compound class:
Synthetic organic
Comment: Bromhexine is a widely used mucolytic (expectorant) drug. In response to the SARS-CoV-2 pandemic of 2019/20 it was investigated as an add-on treatment for patients with COVID-19 [1]. In addition to its mucolytic activity, bromhexine may also inhibit the human protease TMPRSS2 that is exploited by certain coronaviruses for spike (S) protein priming, thus reducing the viruses' infection mechanism [2].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. |
| Is prodrug? | Yes |
| Active form | ambroxol |
IUPAC Name ![]() |
| 2,4-dibromo-6-[[cyclohexyl(methyl)amino]methyl]aniline |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 2584 | bromhexine |
Synonyms ![]() |
| Bisolvon® | NA-274 | NA274 |
Database Links ![]() |
|
| CAS Registry No. | 3572-43-8 (source: ChemIDplus) |
| ChEMBL Ligand | CHEMBL253376 |
| DrugBank Ligand | DB09019 |
| DrugCentral Ligand | 402 |
| GtoPdb PubChem SID | 434122278 |
| PubChem CID | 2442 |
| Search Google for chemical match using the InChIKey | OJGDCBLYJGHCIH-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | OJGDCBLYJGHCIH |
| Search PubMed clinical trials | bromhexine |
| Search PubMed titles | bromhexine |
| Search PubMed titles/abstracts | bromhexine |
| UniChem Compound Search for chemical match using the InChIKey | OJGDCBLYJGHCIH-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | OJGDCBLYJGHCIH-UHFFFAOYSA-N |